Diazepam Intramuscular (Im) / Intravenous (Iv) Injection 5 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Intramuscular (IM) / Intravenous (IV) Injection

Available Strengths: 5 mg/mL

Reference Brands: Valium®(EU & US)

Category: Antipsychotropic Drugs

Diazepam, a benzodiazepine, enhances GABAergic inhibition by binding to GABA-A receptors, leading to sedation, muscle relaxation, anxiolysis, and anticonvulsant effects. IM/IV formulations are used for status epilepticus, severe anxiety, muscle spasms, preoperative sedation, and alcohol withdrawal, offering rapid relief in emergency or acute care settings. Diazepam IM/IV injection is an FDA-approved benzodiazepine for the treatment of status epilepticus, anxiety disorders, muscle spasms, and preoperative sedation. In the U.S., it is classified as a Schedule IV controlled substance. The EMA authorizes its use under centralized or national procedures in EU member states for similar indications. It is considered essential for emergency and critical care, with strict labeling and risk mitigation strategies in both markets. Regular pharmacovigilance reporting ensures compliance with safety standards. Explore other diazepam formulations and global supply opportunities on Pharmatradz.com.

Product Description:

Diazepam is a widely used benzodiazepine for managing anxiety, muscle spasms, seizures, and acute alcohol withdrawal symptoms. Available in tablets, oral solution, rectal gel, and IV/IM injection, Diazepam is marketed under brand names like Valium® and Diastat® in the US, and Valium® or Stesolid® in the EU. Strengths range from 2 mg to 10 mg for oral forms and 5 mg/mL for injectables. As a Schedule IV controlled substance in the US and prescription-regulated in the EU, Diazepam remains a crucial CNS pharmaceutical product. Ideal for B2B pharma suppliers seeking high-demand sedatives for regulated hospital and retail markets.